Equities

Venus Medtech Hangzhou Inc

Venus Medtech Hangzhou Inc

Actions
Health CareMedical Equipment and Services
  • Price (HKD)5.62
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-18.67%
  • Beta1.0480
Data delayed at least 15 minutes, as of Nov 22 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Venus MedTech (HangZhou) Inc. is a China-based company engaged in the research, development, manufacture and sales of minimally invasive medical devices and auxiliary instruments and equipment for the treatment of heart valve diseases. The Company's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8 / TAV8 and TriGUARD3 Cerebral Embolic Protection Device.

  • Revenue in HKD (TTM)530.47m
  • Net income in HKD-759.75m
  • Incorporated2009
  • Employees865.00
  • Location
    Venus Medtech Hangzhou IncRoom 311, 3/F, Block 2, No. 88Jiangling Road, Binjiang DistrictHANGZHOU ChinaCHN
  • Websitehttps://www.venusmedtech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Beijing Airdoc Technology Co Ltd220.19m-143.08m1.31bn339.00--0.7885--5.95-1.38-1.382.1316.060.11912.262.84649,540.60-8.51---9.03--61.35---71.41--11.26--0.006--79.46--26.37------
Sisram Medical Ltd2.80bn245.89m1.41bn1.08k5.750.40063.840.50430.52480.52485.997.540.61471.804.392,597,016.005.635.946.706.8861.1057.669.1610.582.0013.960.086928.791.3618.48-21.597.6146.589.64
IVD Medical Holding Ltd3.33bn257.11m1.45bn803.004.680.33394.880.43390.19020.19022.472.670.67882.785.624,152,108.005.215.186.866.6721.7520.757.687.531.567.530.0923--12.3549.4913.4118.1519.77--
MicroTech Medical Hangzhou Co Ltd273.38m-134.96m1.50bn760.00--0.685--5.50-0.3171-0.31710.64225.230.11372.354.13359,707.80-5.62---5.85--49.13---49.37--21.22--0.00008--45.92---256.75------
Jenscare Scientific Co Ltd0.00-401.32m1.55bn376.00--1.17-----0.962-0.9620.003.190.00----0.00-27.49---28.61----------19.20--0.0347------15.38------
Gaush Meditech Ltd1.52bn187.33m1.66bn869.008.850.91356.171.091.271.2710.2612.260.50572.348.851,746,994.006.22--8.35--49.18--12.30--1.195.900.2814--12.16--149.63------
Peijia Medical Ltd476.23m-423.76m1.75bn1.04k--0.7139--3.68-0.624-0.6240.70113.610.14730.777337.52457,911.70-13.11-34.08-14.94-36.9073.7671.62-88.99-448.756.92--0.0886--75.86--3.75--106.68--
PW Medtech Group Ltd728.80m165.37m1.83bn1.24k11.080.41955.582.510.10560.10560.46552.790.13312.199.21585,854.604.047.234.918.0956.4258.1330.3785.3812.70--0.00024.1125.7516.7844.465.94-7.92--
MicroPort CardioFlow Medtech Corp362.97m-509.06m1.83bn592.00--0.7274--5.05-0.2154-0.21540.15361.040.12052.783.67613,123.30-16.91-17.37-18.11-22.962.06-1.67-140.25-180.829.91-11.560.0293--33.94---3.77---14.16--
Acotec Scientific Holdings Ltd511.55m15.64m1.96bn638.00120.541.4029.963.840.0520.0521.704.470.31360.72133.44801,808.800.9589--1.03--79.65--3.06--9.122.750.1529--19.80---79.35------
Venus MedTech HangZhou Inc530.47m-759.75m2.48bn865.00--0.7861--4.67-1.74-1.741.217.150.10140.94021.65613,264.20-15.04-13.20-17.41-14.9779.2179.51-148.37-152.831.86-8.780.2206--20.8933.6233.46--58.20--
OrbusNeich Medical Group Holdings Ltd1.20bn351.86m2.77bn1.25k7.900.96167.192.300.42260.42261.443.470.40431.344.38961,674.8011.84--12.86--69.22--29.29--8.60--0.0198--12.45--143.76------
China Isotope & Radiation Corp7.16bn400.49m3.42bn3.11k8.550.67553.160.47781.251.2522.3915.840.53124.221.842,306,913.006.216.5712.8213.2652.4859.8911.7012.621.73--0.191928.277.8215.35-5.432.883.632.89
Zylox-Tonbridge Medical Technolgy Co Ltd569.75m-85.00m3.58bn765.00--1.06--6.28-0.2587-0.25871.7310.150.15920.9991480.65744,770.60-2.38---2.56--72.95---14.92--4.88--0.018--57.97--30.66------
Yidu Tech Inc871.30m-210.46m3.64bn902.00--0.8388--4.18-0.2001-0.20010.82854.090.1658114.901.36965,962.60-4.54-35.96-5.35-51.3842.0634.80-27.41-159.716.77--0.0227--0.295351.2368.96------
Data as of Nov 22 2023. Currency figures normalised to Venus Medtech Hangzhou Inc's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 04 Jul 202411.38m0.00%
BlackRock Fund Advisorsas of 04 Jul 20243.50m0.00%
Bosera Asset Management Co., Ltd.as of 31 Dec 20233.22m0.00%
Dimensional Fund Advisors LPas of 04 Jul 20242.53m0.00%
Fidelity Management & Research (Hong Kong) Ltd.as of 31 May 20242.49m0.00%
SEB Investment Management ABas of 28 Jun 20242.20m0.00%
Fidelity Management & Research Co. LLCas of 31 May 20241.73m0.00%
BlackRock Advisors (UK) Ltd.as of 04 Jul 20241.48m0.00%
E Fund Management Co., Ltd.as of 31 Dec 20231.33m0.00%
BC Investment Management Corp.as of 31 Mar 20231.19m0.00%
More ▼
Data from 31 Mar 2024 - 24 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.